Terms: = Endocrine gland cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
57 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic cancer: A Systematic Review and Meta-Analysis.
Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
[TBL] [Abstract] [Full Text] [Related]
3. runx1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.
Yu X; Zhao P; Luo Q; Wu X; Wang Y; Nan Y; Liu S; Gao W; Li B; Liu Z; Cui Z
Oncogene; 2024 Feb; 43(6):420-433. PubMed ID: 38092960
[TBL] [Abstract] [Full Text] [Related]
4. Therapy-related acute myeloid leukemia with
Yang X; Liu Q; Zhang R; Yang X; Wang L; Zhang Z; Li Y; Lin L
Indian J Pathol Microbiol; 2023; 66(4):865-867. PubMed ID: 38084551
[TBL] [Abstract] [Full Text] [Related]
5. runx1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Additional Preoperative Computed Tomography Imaging on Staging, Surgery, and Postsurgical Survival in Patients With Papillary Thyroid Carcinoma.
Jeong SY; Chung SR; Baek JH; Choi YJ; Kim S; Sung TY; Song DE; Kim TY; Lee JH
Korean J Radiol; 2023 Dec; 24(12):1284-1292. PubMed ID: 38016686
[TBL] [Abstract] [Full Text] [Related]
7. Combination of runx1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
She C; Wu C; Guo W; Xie Y; Li S; Liu W; Xu C; Li H; Cao P; Yang Y; Wang X; Chang A; Feng Y; Hao J
J Exp Clin Cancer Res; 2023 Sep; 42(1):238. PubMed ID: 37697370
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a nomogram for assessment postoperative sodium disturbance in PAs patients: a retrospective cohort study.
Li W; Tang D; Wang Q; Li S; Zhao W; You L
PeerJ; 2023; 11():e15946. PubMed ID: 37663278
[TBL] [Abstract] [Full Text] [Related]
9. Intra- and peritumoral radiomics for predicting early recurrence in patients with high-grade serous ovarian cancer.
Wu Y; Jiang W; Fu L; Ren M; Ai H; Wang X
Abdom Radiol (NY); 2023 Feb; 48(2):733-743. PubMed ID: 36445408
[TBL] [Abstract] [Full Text] [Related]
10. PROM1, CXCL8, runx1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.
Dansonka-Mieszkowska A; Szafron LA; Kulesza M; Stachurska A; Leszczynski P; Tomczyk-Szatkowska A; Sobiczewski P; Parada J; Kulinczak M; Moes-Sosnowska J; Pienkowska-Grela B; Kupryjanczyk J; Chechlinska M; Szafron LM
PLoS One; 2022; 17(7):e0271539. PubMed ID: 35867729
[TBL] [Abstract] [Full Text] [Related]
11. Ultrasonography-Guided Thermal Ablation for Cervical Lymph Node Metastasis of Recurrent Papillary Thyroid Carcinoma: Is it Superior to Surgical Resection?
Zhang X; Ni T; Zhang W
Front Endocrinol (Lausanne); 2022; 13():907195. PubMed ID: 35832431
[TBL] [Abstract] [Full Text] [Related]
12. NOXA expression drives synthetic lethality to runx1 inhibition in pancreatic cancer.
Doffo J; Bamopoulos SA; Köse H; Orben F; Zang C; Pons M; den Dekker AT; Brouwer RWW; Baluapuri A; Habringer S; Reichert M; Illendula A; Krämer OH; Schick M; Wolf E; van IJcken WFJ; Esposito I; Keller U; Schneider G; Wirth M
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35197278
[TBL] [Abstract] [Full Text] [Related]
13. Dosimetry impact of gating latency in cine magnetic resonance image guided breath-hold pancreatic cancer radiotherapy.
Hu P; Li X; Liu W; Yan B; Xue X; Yang F; Ford JC; Portelance L; Yang Y
Phys Med Biol; 2022 Feb; 67(5):. PubMed ID: 35144247
[No Abstract] [Full Text] [Related]
14. Using a Nomogram to Preoperatively Predict Distant Metastasis of Pancreatic Neuroendocrine Tumor in Elderly Patients.
Li G; Bing YT; Tian ML; Yuan CH; Xiu DR
Chin Med Sci J; 2021 Sep; 36(3):218-224. PubMed ID: 34666875
[TBL] [Abstract] [Full Text] [Related]
15. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
[TBL] [Abstract] [Full Text] [Related]
16. The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China.
Ni J; Cheng X; Zhao Q; Dai Z; Xu X; Guo W; Gu H; Zhou R; Wang Y; Chen X
J Ovarian Res; 2021 May; 14(1):68. PubMed ID: 33993885
[TBL] [Abstract] [Full Text] [Related]
17. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.
Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF
Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of runx1 promotes cisplatin-induced apoptosis in ovarian cancer cells.
Xiao L; Peng Z; Zhu A; Xue R; Lu R; Mi J; Xi S; Chen W; Jiang S
Biochem Pharmacol; 2020 Oct; 180():114116. PubMed ID: 32579960
[TBL] [Abstract] [Full Text] [Related]
19. Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic cancer.
Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis CU; McGovern D; Lee CK
Pancreas; 2020 Jul; 49(6):744-750. PubMed ID: 32541630
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study.
Garnier J; Ewald J; Marchese U; Gilabert M; Launay S; Moureau-Zabotto L; Poizat F; Giovannini M; Delpero JR; Turrini O
BMC Cancer; 2020 Mar; 20(1):203. PubMed ID: 32164564
[TBL] [Abstract] [Full Text] [Related]
[Next]
